Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
1 clinical trials · Condition
◉ Watch Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
| Record | Firm | Date |
|---|---|---|
| Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors (NCT02144051) | AstraZeneca | 2014-05-01 |
Track Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor automatically
Every clearance here is in the API, with alerts when new ones post.